Warrell RP Jr - Search Results

1

Reply to 'Arsenic patent keeps drug for rare cancer out of reach for many'.

Warrell RP Jr. Warrell RP Jr. Nat Med. 2007 Nov;13(11):1278. doi: 10.1038/nm1107-1278. Nat Med. 2007. PMID: 17987017 No abstract available.

2

Randomized, double-blind, phase II trial of gallium nitrate compared with pamidronate for acute control of cancer-related hypercalcemia.

Cvitkovic F, Armand JP, Tubiana-Hulin M, Rossi JF, Warrell RP Jr. Cvitkovic F, et al. Among authors: warrell rp jr. Cancer J. 2006 Jan-Feb;12(1):47-53. doi: 10.1097/00130404-200601000-00009. Cancer J. 2006. PMID: 16613662 Clinical Trial.

3

Frequent mutations in the ligand-binding domain of PML-RARalpha after multiple relapses of acute promyelocytic leukemia: analysis for functional relationship to response to all-trans retinoic acid and histone deacetylase inhibitors in vitro and in vivo.

Zhou DC, Kim SH, Ding W, Schultz C, Warrell RP Jr, Gallagher RE. Zhou DC, et al. Among authors: warrell rp jr. Blood. 2002 Feb 15;99(4):1356-63. doi: 10.1182/blood.v99.4.1356. Blood. 2002. PMID: 11830487 Free article.

4

Histone deacetylase inhibitors induce remission in transgenic models of therapy-resistant acute promyelocytic leukemia.

He LZ, Tolentino T, Grayson P, Zhong S, Warrell RP Jr, Rifkind RA, Marks PA, Richon VM, Pandolfi PP. He LZ, et al. Among authors: warrell rp jr. J Clin Invest. 2001 Nov;108(9):1321-30. doi: 10.1172/JCI11537. J Clin Invest. 2001. PMID: 11696577 Free PMC article.

5

Prognostic significance of minimal residual disease detection and PML/RAR-alpha isoform type: long-term follow-up in acute promyelocytic leukemia.

Jurcic JG, Nimer SD, Scheinberg DA, DeBlasio T, Warrell RP Jr, Miller WH Jr. Jurcic JG, et al. Among authors: warrell rp jr. Blood. 2001 Nov 1;98(9):2651-6. doi: 10.1182/blood.v98.9.2651. Blood. 2001. PMID: 11675334 Free article.

6

United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia.

Soignet SL, Frankel SR, Douer D, Tallman MS, Kantarjian H, Calleja E, Stone RM, Kalaycio M, Scheinberg DA, Steinherz P, Sievers EL, Coutré S, Dahlberg S, Ellison R, Warrell RP Jr. Soignet SL, et al. Among authors: warrell rp jr. J Clin Oncol. 2001 Sep 15;19(18):3852-60. doi: 10.1200/JCO.2001.19.18.3852. J Clin Oncol. 2001. PMID: 11559723 Clinical Trial.

7

Differentiating agents in pediatric malignancies: all-trans-retinoic acid and arsenic in acute promyelocytic leukemia.

Calleja EM, Warrell RP Jr. Calleja EM, et al. Among authors: warrell rp jr. Curr Oncol Rep. 2000 Nov;2(6):519-23. doi: 10.1007/s11912-000-0105-x. Curr Oncol Rep. 2000. PMID: 11122887 Review.

8

Inhaled aerosolization of all-trans-retinoic acid for targeted pulmonary delivery.

Brooks AD, Tong W, Benedetti F, Kaneda Y, Miller V, Warrell RP Jr. Brooks AD, et al. Among authors: warrell rp jr. Cancer Chemother Pharmacol. 2000;46(4):313-8. doi: 10.1007/s002800000148. Cancer Chemother Pharmacol. 2000. PMID: 11052629

9

Arsenicals in hematologic cancers.

Novick SC, Warrell RP Jr. Novick SC, et al. Among authors: warrell rp jr. Semin Oncol. 2000 Oct;27(5):495-501. Semin Oncol. 2000. PMID: 11049017 Review.

10

Retinoic acid (RA) and As2O3 treatment in transgenic models of acute promyelocytic leukemia (APL) unravel the distinct nature of the leukemogenic process induced by the PML-RARalpha and PLZF-RARalpha oncoproteins.

Rego EM, He LZ, Warrell RP Jr, Wang ZG, Pandolfi PP. Rego EM, et al. Among authors: warrell rp jr. Proc Natl Acad Sci U S A. 2000 Aug 29;97(18):10173-8. doi: 10.1073/pnas.180290497. Proc Natl Acad Sci U S A. 2000. PMID: 10954752 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

117 results

Search Page